Health CanadaGeneral Alert
BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect
Published: October 23, 2015Recall ID: 54282Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect
Additional Source Details
| Field | Value |
|---|---|
| N I D | 54282 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/bravelle-75-iu-urofollitropin-injection-purified-recalled-lots-due-reduced-therapeutic |
| Issue | Product safety |
| Title | BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2015-10-23 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect Check if your household is affected: https://therecallfile.com/recalls/bravelle-75-iu-urofollitropin-for-injection-purified-recalled-lots-due/CANADA-54282
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordBRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic Effect